NCT06969417View on ClinicalTrials.gov

Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

September 30, 2025

Conditions
Herpes Zoster (HZ)Post Herpetic Neuralgia (PHN)
Interventions
DRUG

Pregabalin

o Group A will receive Cap Pregabalin 150mg oral OD for 4 weeks

DRUG

Lacosamide

o Group B will receive Tab Lacosamide 100mg oral BD for 4 weeks

Trial Locations (1)

50070

RECRUITING

CMH Kharian Medical College, Kharan

All Listed Sponsors
lead

CMH Kharian Medical College

OTHER_GOV

NCT06969417 - Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia | Biotech Hunter | Biotech Hunter